Nexalin Technology, Inc. (NXLIW)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.63 Million USD | -51.13% |
| 2022 | 7.43 Million USD | 886.09% |
| 2021 | 753.69 Thousand USD | 536.24% |
| 2020 | 118.46 Thousand USD | 5.29% |
| 2019 | 112.5 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.83 Million USD | -21.96% |
| 2024 Q2 | 1.56 Million USD | -44.85% |
| 2023 FY | 3.63 Million USD | -51.13% |
| 2023 Q2 | 5.17 Million USD | -12.73% |
| 2023 Q3 | 4.43 Million USD | -14.33% |
| 2023 Q1 | 5.93 Million USD | -20.2% |
| 2023 Q4 | 3.63 Million USD | -18.09% |
| 2022 Q2 | 556.26 Thousand USD | -16.1% |
| 2022 FY | 7.43 Million USD | 886.09% |
| 2022 Q1 | 663.03 Thousand USD | -12.03% |
| 2022 Q4 | 7.43 Million USD | -11.02% |
| 2022 Q3 | 8.35 Million USD | 1401.58% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 753.69 Thousand USD | 536.24% |
| 2021 Q4 | 753.69 Thousand USD | 306.49% |
| 2021 Q3 | 185.41 Thousand USD | -48.36% |
| 2021 Q2 | 359.04 Thousand USD | 0.0% |
| 2020 Q4 | 118.46 Thousand USD | 0.0% |
| 2020 FY | 118.46 Thousand USD | 5.29% |
| 2019 FY | 112.5 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 88.421% |
| BrainsWay Ltd. | 62.97 Million USD | 94.232% |
| Cerus Corporation | 197.74 Million USD | 98.163% |
| Envoy Medical, Inc. | 7.64 Million USD | 52.462% |
| electroCore, Inc. | 16.38 Million USD | 77.837% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | 52.783% |
| IceCure Medical Ltd | 16.41 Million USD | 77.868% |
| Inogen, Inc. | 326.19 Million USD | 98.887% |
| OrthoPediatrics Corp. | 449.58 Million USD | 99.192% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 86.682% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 78.093% |
| MaxCyte, Inc. | 268.27 Million USD | 98.646% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 55.147% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.607% |
| PAVmed Inc | 33.11 Million USD | 89.034% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 97.468% |
| RxSight, Inc. | 182.55 Million USD | 98.01% |
| Sight Sciences, Inc. | 166.65 Million USD | 97.821% |
| SI-BONE, Inc. | 230.42 Million USD | 98.424% |
| TELA Bio, Inc. | 78.04 Million USD | 95.347% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 98.558% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 66.152% |
| Acutus Medical, Inc. | 53.96 Million USD | 93.269% |
| Talis Biomedical Corporation | 98.34 Million USD | 96.307% |
| Spectral AI, Inc. | 10.69 Million USD | 66.031% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 98.339% |
| CVRx, Inc. | 115.22 Million USD | 96.848% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 93.809% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -16.585% |
| Bioventus Inc. | 810.91 Million USD | 99.552% |
| Venus Concept Inc. | 93.65 Million USD | 96.122% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 85.882% |
| LivaNova PLC | 2.42 Billion USD | 99.851% |
| 908 Devices Inc. | 202.98 Million USD | 98.211% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.549% |
| Nemaura Medical Inc. | 14.56 Million USD | 75.061% |
| NeuroPace, Inc. | 107.65 Million USD | 96.626% |
| LENSAR, Inc. | 69.58 Million USD | 94.781% |
| Apyx Medical Corporation | 79.24 Million USD | 95.417% |
| Cutera, Inc. | 346.29 Million USD | 98.951% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 91.356% |
| BioSig Technologies, Inc. | 1.79 Million USD | -101.998% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 98.658% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 91.487% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.904% |
| Axonics, Inc. | 719.92 Million USD | 99.496% |
| Outset Medical, Inc. | 313.8 Million USD | 98.843% |
| IRIDEX Corporation | 34.43 Million USD | 89.453% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 99.103% |
| IRadimed Corporation | 92.15 Million USD | 96.059% |
| Tivic Health Systems, Inc. | 5.25 Million USD | 30.873% |
| INVO Bioscience, Inc. | 20.88 Million USD | 82.612% |
| Telesis Bio, Inc. | 70.41 Million USD | 94.842% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 97.643% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.709% |
| Quipt Home Medical Corp. | 247.4 Million USD | 98.532% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 60.989% |
| Pulmonx Corporation | 178.95 Million USD | 97.97% |
| Dynatronics Corporation | 25.94 Million USD | 85.999% |
| Modular Medical, Inc. | 13.8 Million USD | 73.695% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 66.142% |
| Semler Scientific, Inc. | 78.06 Million USD | 95.348% |
| InMode Ltd. | 863.28 Million USD | 99.579% |
| Bruker Corporation | 4.24 Billion USD | 99.915% |
| Cytosorbents Corporation | 53.26 Million USD | 93.181% |
| DexCom, Inc. | 6.26 Billion USD | 99.942% |
| Align Technology, Inc. | 6.08 Billion USD | 99.94% |
| Viveve Medical, Inc. | 25.91 Million USD | 85.984% |
| ZimVie Inc. | 1.2 Billion USD | 99.699% |
| Movano Inc. | 9.42 Million USD | 61.449% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 99.27% |
| Nexalin Technology, Inc. | 3.63 Million USD | 0.0% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 93.809% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.619% |
| Profound Medical Corp. | 43.68 Million USD | 91.686% |
| Insulet Corporation | 2.58 Billion USD | 99.86% |
| enVVeno Medical Corporation | 48.63 Million USD | 92.532% |
| Surmodics, Inc. | 185.73 Million USD | 98.045% |
| iCAD, Inc. | 41.41 Million USD | 91.231% |
| Nuwellis, Inc. | 9.77 Million USD | 62.826% |
| Biotricity, Inc. | 5.94 Million USD | 38.884% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 99.161% |
| Aethlon Medical, Inc. | 8.24 Million USD | 55.955% |
| InspireMD, Inc. | 47.64 Million USD | 92.377% |
| PAVmed Inc. | 33.11 Million USD | 89.034% |
| BIOLASE, Inc. | 35.1 Million USD | 89.653% |
| Beyond Air, Inc. | 56.96 Million USD | 93.624% |
| FONAR Corporation | 214.24 Million USD | 98.305% |
| AxoGen, Inc. | 196.82 Million USD | 98.155% |
| Vivani Medical, Inc. | 45.79 Million USD | 92.07% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 98.71% |
| Inari Medical, Inc. | 674.23 Million USD | 99.461% |
| UFP Technologies, Inc. | 404.13 Million USD | 99.101% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 84.478% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 61.782% |
| Tenon Medical, Inc. | 6.34 Million USD | 42.759% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 61.391% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 96.496% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.921% |
| Sintx Technologies, Inc. | 15.36 Million USD | 76.362% |
| NanoVibronix, Inc. | 6.67 Million USD | 45.581% |
| Quanterix Corporation | 425.01 Million USD | 99.145% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 60.989% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 93.24% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.792% |
| TransMedics Group, Inc. | 706.04 Million USD | 99.486% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 94.253% |
| NeuroMetrix, Inc. | 21.42 Million USD | 83.048% |
| Hyperfine, Inc. | 94.19 Million USD | 96.144% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 98.648% |
| Biomerica, Inc. | 9.25 Million USD | 60.753% |
| Bone Biologics Corporation | 3.73 Million USD | 2.832% |
| AVITA Medical, Inc. | 144.33 Million USD | 97.484% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | 25.4% |
| Silk Road Medical, Inc | 265.3 Million USD | 98.631% |